Last reviewed · How we verify
TCM Syndrome Differentiation Decoction — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
TCM Syndrome Differentiation Decoction (TCM Syndrome Differentiation Decoction) — Guangzhou University of Traditional Chinese Medicine. A personalized herbal decoction formulated according to Traditional Chinese Medicine syndrome differentiation principles to restore balance and treat disease-specific patterns.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TCM Syndrome Differentiation Decoction TARGET | TCM Syndrome Differentiation Decoction | Guangzhou University of Traditional Chinese Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TCM Syndrome Differentiation Decoction CI watch — RSS
- TCM Syndrome Differentiation Decoction CI watch — Atom
- TCM Syndrome Differentiation Decoction CI watch — JSON
- TCM Syndrome Differentiation Decoction alone — RSS
Cite this brief
Drug Landscape (2026). TCM Syndrome Differentiation Decoction — Competitive Intelligence Brief. https://druglandscape.com/ci/tcm-syndrome-differentiation-decoction. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab